Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit.
- Products
-
- Duloxetine Delayed-Release Capsules
- Company
- Rising Pharma Holding, Inc.
- Where it was sold
-
Nationwide in the USA.
Nationwide
- Units affected
- 1223 bottles
- About this recall
- Duloxetine Delayed-Release Capsules, USP, 30 mg, 1,000-count bottle, Rx only, Distributed by: Rising Health, LLC, Saddle Brook, NJ 07663, NDC 57237-018-99